Update on disposal of entire investment (i.e. Equity & Preference shares) held by the Company in Dinesh Remedies Limited.

Core business divestedStrategic Transactions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.7%Reaction day

₹283.50

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.7%+2.3% vs market

Other Textile Products peers, median of 173sector-0.1%+1.8% vs sector

On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250 and 1.8 pts more than its Other Textile Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.7-0.7+2.3-0.1+1.8

Next day

+1.5-0.7+2.2+0.0+1.5

+1.0-0.2+1.3-0.0+1.1

-0.1-0.1-0.1-0.2+0.1

+0.2+0.4-0.2+0.3-0.0

+1.9+0.3+1.6+0.4+1.5

+1.1+1.0+0.1+1.3-0.2

15d

-0.5-0.2-0.3-0.3-0.3

+4.3-1.2+5.5-2.2+6.5

+1.0+0.6+0.4-2.1+3.1

-10.5-4.3-6.2-6.8-3.6

UpDownMarket · Nifty Microcap 250Sector · Other Textile Products peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shri Dinesh Mills Ltd has completed the sale of its entire stake (both equity and preference shares) in subsidiary Dinesh Remedies Ltd on 3rd September 2025. The buyer is Mr. Dixit Rashmikantbhai Patel and his affiliates, who were existing shareholders of Dinesh Remedies. The company received total consideration of about Rs. 5.43 crore (Rs. 3.14 crore for equity shares and Rs. 2.29 crore for optionally convertible preference shares). With this disposal, Dinesh Remedies has ceased to be a subsidiary. Notably, Dinesh Remedies contributed about 30% of consolidated turnover (Rs. 34.29 crore) but only 5.94% of consolidated net worth, and was incurring persistent losses. Shareholders had earlier approved the deal via postal ballot in December 2024.

Likely market impact

The exit removes a loss-making subsidiary that was a drag on consolidated financials, which is a positive for shareholders. The disposal should simplify the business and potentially improve profitability, though the cash received is relatively small compared to the size of the company.